EichorEICHOR
Location: Manhattan Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Manhattan

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Phase 4 · Westat · NCT06738407A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Pfizer · NCT05020236A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · Erasca, Inc. · NCT06983743A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · AbbVie · NCT06602479A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT07359859BioHealx® Anal Fistula Device Post Market Surveillance Study
Phase N/A · Signum Surgical USA Inc. · NCT07021742KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Merck Sharp & Dohme LLC · NCT04165070Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Phase N/A · Icahn School of Medicine at Mount Sinai · NCT06288282A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06728579PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
Phase N/A · NYU Langone Health · NCT07184970Cognitive Reappraisal Training for Borderline Personality (BPD)
NA · Icahn School of Medicine at Mount Sinai · NCT06772831Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Pharmaceuticals · NCT05755386A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Sanofi · NCT06867094This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Arkansas Children's Hospital Research Institute · NCT03827694Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
NA · Boston Scientific Corporation · NCT07575269A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · Edwards Lifesciences · NCT05172973A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Takeda · NCT06747351A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Phase 1/Phase 2 · AskGene Pharma, Inc. · NCT05867420Project I Test: Implementing HIV Testing in Opioid Treatment Programs
NA · Columbia University · NCT03135886Community Care Intervention to Decrease COVID-19 Vaccination Inequities
NA · RAND · NCT06156254N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06528496E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
Phase 2 · NYU Langone Health · NCT05722561A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Phase 1/Phase 2 · Spirovant Sciences, Inc. · NCT06526923Incremental Hemodialysis: The TwoPlus Trial
NA · Wake Forest University Health Sciences · NCT05828823Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.